AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22647278 — intervention group
Group type: COMPARATOR
Intervention: Control group (completed regular curriculum)
Number of subjects: 43
Study 20306185 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg three times daily for 7 days
Number of subjects: 12
Study 20306185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17852012 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUG) test
Number of subjects: 31
Study 17852012 — intervention group
Group type: EXPERIMENTAL
Intervention: TUG test
Number of subjects: 31
Study 16051944 — intervention group
Group type: EXPERIMENTAL
Intervention: FU/DOX
Number of subjects: 249
Study 16051944 — intervention group
Group type: EXPERIMENTAL
Intervention: FU/STZ
Number of subjects: 249
Study 16051944 — intervention group
Group type: COMPARATOR
Intervention: DTIC
Number of subjects: 249
Study 12392445 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT)
Number of subjects: 0
Study 12392445 — intervention group
Group type: COMPARATOR
Intervention: Placebo ESWT
Number of subjects: 0
Study 11195609 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/HCTZ 12.5 mg
Number of subjects: 222
Study 11195609 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg/HCTZ 12.5 mg
Number of subjects: 222
Study 9934058 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition without interruption (WI)
Number of subjects: 69
Study 9934058 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition with a 7-hour nightly rest (NR)
Number of subjects: 69
Study 7880215 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 MAC of isoflurane
Number of subjects: 6
Study 7880215 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 MAC of isoflurane + 0.6 MAC of N2O
Number of subjects: 6
Study 7880215 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1 MAC of isoflurane + 0.6 MAC of N2O
Number of subjects: 6
Study 7880215 — intervention group
Group type: COMPARATOR
Intervention: 1.1 MAC of isoflurane
Number of subjects: 6
Study 3047920 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of iron per day, as ferrous gluconate
Number of subjects: 0
Study 3047920 — intervention group
Group type: COMPARATOR
Intervention: Calcium phosphate placebo
Number of subjects: 0
Study 29380821 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten (10 g/daily)
Number of subjects: 36
Study 29380821 — intervention group
Group type: COMPARATOR
Intervention: Placebo (rice starch)
Number of subjects: 36
Study 28323305 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Intervention (EI)
Number of subjects: 49
Study 28323305 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control (WLC)
Number of subjects: 49
Study 25079374 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,2‐(13) C‐DCA
Number of subjects: 17
Study 23292034 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid formula
Number of subjects: 78
Study 23292034 — intervention group
Group type: COMPARATOR
Intervention: Powdered formula
Number of subjects: 78
Study 21823173 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol at 0.05% BAC
Number of subjects: 27
Study 21823173 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol at 0.08% BAC
Number of subjects: 27
Study 21823173 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol at 0.11% BAC
Number of subjects: 27
Study 21823173 — intervention group
Group type: COMPARATOR
Intervention: Placebo-alcohol
Number of subjects: 27
Study 18362301 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-caloric diet (LCD; 600 kcal/d less than energy requirements)
Number of subjects: 40
Study 17157575 — intervention group
Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 122
Study 17157575 — intervention group
Group type: COMPARATOR
Intervention: LASIK
Number of subjects: 122
Study 12712084 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipelle biopsy
Number of subjects: 32
Study 12712084 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen section
Number of subjects: 32
Study 11061197 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-tibial amputees (TTA)
Number of subjects: 0
Study 11061197 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study 8607960 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine (10 mg by mouth daily)
Number of subjects: 14
Study 8607960 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine (60 mg by mouth twice daily)
Number of subjects: 14
Study 8607960 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 8607960 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine and terfenadine
Number of subjects: 14
Study 1443846 — intervention group
Group type: EXPERIMENTAL
Intervention: One minute of TENS
Number of subjects: 15
Study 1443846 — intervention group
Group type: EXPERIMENTAL
Intervention: Ten minutes of TENS
Number of subjects: 15
Study 1443846 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 minutes of TENS
Number of subjects: 15
Study 1443846 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 15
Study 31170114 — intervention group
Group type: EXPERIMENTAL
Intervention: Home biofeedback
Number of subjects: 100
Study 31170114 — intervention group
Group type: COMPARATOR
Intervention: Office biofeedback
Number of subjects: 100
Study 30183102 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 5234
Study 30183102 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo/ezetimibe)
Number of subjects: 5234
Study 27323555 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF) after separation from CPB
Number of subjects: 80
Study 27323555 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MUF)
Number of subjects: 80
Study 27323555 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF)
Number of subjects: 80
Study 24103462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasolabial flap (Group I, n = 10)
Number of subjects: 20
Study 24103462 — intervention group
Group type: COMPARATOR
Intervention: Buccal fat pad (BFP) (Group II, n = 10)
Number of subjects: 20
Study 23477161 — intervention group
Group type: EXPERIMENTAL
Intervention: Maixuekang capsule combined with conventional therapy for 3 months
Number of subjects: 120
Study 23477161 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 120
Study 29648531 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone (300 mg tablet)
Number of subjects: 0
Study 29648531 — intervention group
Group type: COMPARATOR
Intervention: Ritmonorm® (300 mg tablet)
Number of subjects: 0
Study 17288686 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5 mg
Number of subjects: 25
Study 17288686 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5 mg plus alcohol (0.1% BAC)
Number of subjects: 25
Study 17288686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 17288686 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus alcohol (0.1% BAC)
Number of subjects: 25
Study 17288686 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine 7.5 mg vs. placebo with alcohol
Number of subjects: 25
Study 15664577 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced tube current settings (60‐75, 76‐90, and 91‐130 mA for thoracic, abdominal, and pelvic examinations; 76‐90 and 91‐130 mA for cranial examinations)
Number of subjects: 0
Study 15664577 — intervention group
Group type: COMPARATOR
Intervention: Conventional tube current settings (180‐240 mA)
Number of subjects: 0
Study 12140664 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupirtine 50 mg
Number of subjects: 21
Study 12140664 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupirtine 100 mg
Number of subjects: 21
Study 12140664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 9987141 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted influenza vaccine (FLUAD, Chiron Vaccines)
Number of subjects: 92
Study 9987141 — intervention group
Group type: COMPARATOR
Intervention: Conventional non-adjuvanted influenza vaccine
Number of subjects: 92
Study 7762525 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg beta-carotene/d for 6 d as synthetic all-trans-beta-carotene
Number of subjects: 24
Study 7762525 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural beta-carotene preparation (50:50 mixture of all-trans- and 6-cis-beta-carotene)
Number of subjects: 24
Study 7762525 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg all-trans-beta-carotene or either 66 or 100 mg of the natural 50:50 isomeric mixture (alternate-day supplementation for 23 d)
Number of subjects: 24
Study 7762525 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 24
Study 2405112 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus additional motivational intervention (feedback about exhaled CO values, spirometry results, and pulmonary symptoms)
Number of subjects: 90
Study 2405112 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus additional motivational intervention
Number of subjects: 90
Study 2405112 — intervention group
Group type: COMPARATOR
Intervention: Education alone (control group)
Number of subjects: 90
Study 6101792 — intervention group
Group type: EXPERIMENTAL
Intervention: Periconceptional multivitamin supplementation
Number of subjects: 438
Study 6101792 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented mothers
Number of subjects: 438
Study 30738021 — intervention group
Group type: EXPERIMENTAL
Intervention: Teen Online Problem‐Solving‐Teen Only (TOPS‐TO)
Number of subjects: 152
Study 30738021 — intervention group
Group type: EXPERIMENTAL
Intervention: Teen Online Problem‐Solving with Family (TOPS‐F)
Number of subjects: 152
Study 30738021 — intervention group
Group type: COMPARATOR
Intervention: Internet resource comparison (IRC)
Number of subjects: 152
Study 28687348 — intervention group
Group type: EXPERIMENTAL
Intervention: LOVED program (interactive web-based app with video education modules and group video chat sessions)
Number of subjects: 60
Study 28687348 — intervention group
Group type: EXPERIMENTAL
Intervention: LOVED program
Number of subjects: 60
Study 28687348 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study 27121224 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-neurofeedback
Number of subjects: 75
Study 27121224 — intervention group
Group type: COMPARATOR
Intervention: Mental imagery
Number of subjects: 75
Study 27121224 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 75
Study 24375756 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fluoride toothpaste (5000 ppm fluoride)
Number of subjects: 424
Study 24375756 — intervention group
Group type: COMPARATOR
Intervention: Regular toothpaste (1450 ppm fluoride)
Number of subjects: 424
Study 21482119 — intervention group
Group type: EXPERIMENTAL
Intervention: Two anterolateral lag screws
Number of subjects: 40
Study 21482119 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteromedial Limited Contact Dynamic Compression Plate (LC‐DCP)
Number of subjects: 40
Study 21482119 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral locking plate
Number of subjects: 40
Study 21482119 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral buttress plate
Number of subjects: 40
Study 19068191 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox
Number of subjects: 1480
Study 19068191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 1480
Study 19068191 — intervention group
Group type: COMPARATOR
Intervention: Deferiprone
Number of subjects: 1480
Study 19068191 — intervention group
Group type: COMPARATOR
Intervention: DFO
Number of subjects: 1480
Study 17335365 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival chlorhexidine varnish administration
Number of subjects: 33
Study 17335365 — intervention group
Group type: COMPARATOR
Intervention: Same-day full-mouth root planing
Number of subjects: 33
Study 15252293 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (200 mg/day) for 14 weeks
Number of subjects: 100
Study 15252293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 11483123 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended interventions (mail only, infrequent telephone and mail, or frequent telephone and mail)
Number of subjects: 117
Study 11483123 — intervention group
Group type: COMPARATOR
Intervention: Computer and provider counseling components (no further contact)
Number of subjects: 117
Study 11483123 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeting a behavior
Number of subjects: 117
Study 10201553 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.0 g ispaghula/day
Number of subjects: 340
Study 10201553 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.5 g ispaghula/day
Number of subjects: 340
Study 10201553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 10201553 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula and modification of diet
Number of subjects: 340
Study 7822917 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression glove and early mobilization
Number of subjects: 42
Study 7822917 — intervention group
Group type: COMPARATOR
Intervention: Plaster splint
Number of subjects: 42
Study 3243671 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal visualization (imaging with eyes closed)
Number of subjects: 52
Study 3243671 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 52
Study 31241036 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured peer-led diabetes self-management and support
Number of subjects: 0
Study 28468518 — intervention group
Group type: EXPERIMENTAL
Intervention: sublingual buprenorphine
Number of subjects: 63
Study 28468518 — intervention group
Group type: COMPARATOR
Intervention: oral morphine
Number of subjects: 63
Study 25041464 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Desirability Scale‐17
Number of subjects: 1243
Study 25041464 — intervention group
Group type: EXPERIMENTAL
Intervention: School education
Number of subjects: 1243
Study 23331802 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics administered to 32 patients for 3 months post-pullthrough
Number of subjects: 62
Study 23331802 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered for 3 months post-pullthrough
Number of subjects: 62
Study 21418830 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 320
Study 21418830 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic papillary balloon dilation (EPBD)
Number of subjects: 320
Study 19748859 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea/sage spray
Number of subjects: 154
Study 19748859 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine/lidocaine spray
Number of subjects: 154
Study 18193695 — intervention group
Group type: COMPARATOR
Intervention: Secnidazole tablet (reference)
Number of subjects: 18
Study 18193695 — intervention group
Group type: EXPERIMENTAL
Intervention: Secnidazole capsule (test)
Number of subjects: 18
Study 15867048 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 and omega-6 fatty acids supplementation
Number of subjects: 117
Study 15867048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 15867048 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (continuing omega-3 and omega-6 fatty acids)
Number of subjects: 117
Study 12186120 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (L-AMP-LRC-1)
Number of subjects: 34
Study 12186120 — intervention group
Group type: COMPARATOR
Intervention: Conventional amphotericin B (c-amp B)
Number of subjects: 34
Study 9719718 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane/N2O
Number of subjects: 100
Study 9719718 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane/N2O
Number of subjects: 100
Study 9719718 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia
Number of subjects: 100
Study 9719718 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl/N2O
Number of subjects: 100
Study 9719718 — intervention group
Group type: COMPARATOR
Intervention: All anesthetic techniques
Number of subjects: 100
Study 7867677 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmin 370 (100 mg)
Number of subjects: 12
Study 7867677 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmin 370 (200 mg)
Number of subjects: 12
Study 7867677 — intervention group
Group type: COMPARATOR
Intervention: Desmin 370 (100 mg and 200 mg)
Number of subjects: 12
Study 2768826 — intervention group
Group type: EXPERIMENTAL
Intervention: cromakalim (n = 12)
Number of subjects: 18
Study 2768826 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 6)
Number of subjects: 18
Study 773589 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of methyl‐CCNU and imidazole carboxamide (DTIC)
Number of subjects: 44
Study 773589 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin
Number of subjects: 44
Study 30783954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 155
Study 30783954 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus Clopidogrel
Number of subjects: 155
Study 30783954 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 155
Study 30783954 — intervention group
Group type: COMPARATOR
Intervention: Control (Healthy subjects receiving no-stent or antiplatelet therapy)
Number of subjects: 155
Study 28150023 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 mg transdermal nicotine
Number of subjects: 44
Study 28150023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 26254154 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonography
Number of subjects: 40
Study 26254154 — intervention group
Group type: COMPARATOR
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 40
Study 24579275 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride group (FG, biannual application of fluoride varnish)
Number of subjects: 400
Study 24579275 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, no intervention)
Number of subjects: 400
Study 21469195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged release (PR) 2-24 mg/d
Number of subjects: 350
Study 21469195 — intervention group
Group type: COMPARATOR
Intervention: Ropinirole immediate release (IR) 0.75-24 mg/d
Number of subjects: 350
Study 18342844 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided detection (CAD) system for lung nodule identification
Number of subjects: 39
Study 16824155 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational-behavioral intervention (IG) including one home visit and three telephone interviews.
Number of subjects: 18
Study 16824155 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care group (EUCG) receiving usual clinical care.
Number of subjects: 18
Study 16824155 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational-behavioral intervention (IG) after three months.
Number of subjects: 18
Study 16824155 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IG and EUCG) at nine months.
Number of subjects: 18
Study 14614930 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft shoe condition
Number of subjects: 40
Study 14614930 — intervention group
Group type: COMPARATOR
Intervention: Hard shoe condition
Number of subjects: 40
Study 10223244 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tumors
Number of subjects: 25
Study 10223244 — intervention group
Group type: EXPERIMENTAL
Intervention: Metastatic tumors
Number of subjects: 25
Study 10223244 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched primary and metastatic tumors
Number of subjects: 25
Study 10223244 — intervention group
Group type: COMPARATOR
Intervention: Primary and metastatic tumors
Number of subjects: 25
Study 7797652 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal construct counseling
Number of subjects: 75
Study 7797652 — intervention group
Group type: COMPARATOR
Intervention: Not counseled (Control)
Number of subjects: 75
Study 2153006 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (300 mg orally every 12 hours)
Number of subjects: 62
Study 2153006 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin/polymyxin (vancomycin 500 mg orally every 8 hours and polymyxin 100 mg orally every 8 hours)
Number of subjects: 62
Study 391500 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 percent amcinonide cream
Number of subjects: 0
Study 391500 — intervention group
Group type: COMPARATOR
Intervention: 0.1 percent betamethasone valerate cream
Number of subjects: 0
Study 31439681 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal vitamin D supplementation
Number of subjects: 2
Study 31439681 — intervention group
Group type: COMPARATOR
Intervention: Control human bronchial epithelial cell line
Number of subjects: 2
Study 31439681 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk CC genotype
Number of subjects: 2
Study 28034719 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait training with body weight support on a treadmill (n=14)
Number of subjects: 28
Study 28034719 — intervention group
Group type: COMPARATOR
Intervention: Gait training with body weight support overground (n=14)
Number of subjects: 28
Study 25086646 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Training (HIFT), 60-minute sessions of CrossFit™, workouts ranging from 5-30 minutes, 3 sessions per week
Number of subjects: 23
Study 25086646 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Aerobic and Resistance Training (ART), 50 minutes of moderate aerobic exercise and full-body resistance training on two sessions per week, 3 sessions per week
Number of subjects: 23
Study 22269279 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (AP) treatment
Number of subjects: 36
Study 22269279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 19466633 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg caffeine
Number of subjects: 18
Study 19466633 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 18
Study 19466633 — intervention group
Group type: EXPERIMENTAL
Intervention: 440-calorie breakfast
Number of subjects: 18